arrow_back Back to App

NIH Reform: Dividing Allergy and Infectious Diseases Institute

This act splits the existing National Institute of Allergy and Infectious Diseases into three separate research institutes. The goal is to better focus on research into allergies, infectious diseases, and immunological diseases, potentially accelerating the development of new treatments and prevention methods, impacting public health.
Key points
Three new institutes are created: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
Directors of these new institutes will be appointed by the President with Senate consent for five-year terms, increasing oversight and accountability.
The changes aim to streamline research and health information dissemination in key medical areas, potentially leading to improved healthcare for citizens.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_1497
Sponsor: Rep. Roy, Chip [R-TX-21]
Process start date: 2025-02-21
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

NIH Reform Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_1497.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-02-21.

What are the main provisions?

Key points include:

  • Three new institutes are created: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
  • Directors of these new institutes will be appointed by the President with Senate consent for five-year terms, increasing oversight and accountability.
  • The changes aim to streamline research and health information dissemination in key medical areas, potentially leading to improved healthcare for citizens.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Roy, Chip [R-TX-21].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health